As representatives of patients and advocates, we are deeply committed to ensuring equitable access to essential oncology medications for all patients burdened by the challenges of cancer, especially for those living in low and middle-income countries (LMICs) who face...
NM Genomix (Bulgaria) and OncoInv (the Netherlands) have joined forces to make multi cancer early detection available in Bulgaria. OncoSeek® is a patient-friendly product to detect cancer as it is on a blood sample and requires no biopsy or imaging equipment. Starting...
Professor Löwenberg is a clinical haematologist and investigator and Emeritus Professor of Haematology at Erasmus University Rotterdam. Professor Löwenberg completed a PhD in Experimental Haematology at Erasmus University Rotterdam and Radiobiological Institute TNO...
SeekIn and OncoInv have joined forces to make multi-cancer early detection (MCED) accessible in low- and middle-income countries (LMICs). SeekIn has developed several blood-based solutions to simplify and enhance cancer diagnosis and analysis. This technology can be...
Rare diseases are defined in the European Union as diseases with a prevalence of fewer than 5 cases out of a population of 10 000. In terms of cancers, 24% of all new cases are rare which means they belong to both categories of cancers and rare diseases. Joint Action...
